Cargando…
Pharmacists expand access to reproductive heaLthcare: PEARL study protocol
BACKGROUND: In 2016, Oregon became the first of eight states to allow pharmacists to directly prescribe hormonal contraception (HC), including the pill, patch, or ring, without a clinic visit. In the two years following this policy change, the majority of ZIP codes across the state of Oregon had a p...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444429/ https://www.ncbi.nlm.nih.gov/pubmed/30935394 http://dx.doi.org/10.1186/s12913-019-4038-9 |
_version_ | 1783408030220550144 |
---|---|
author | Rodriguez, Maria I. Darney, Blair G. Edelman, Alison B. Yee, Kimberly Anderson, Lorinda B. McConnell, K. John |
author_facet | Rodriguez, Maria I. Darney, Blair G. Edelman, Alison B. Yee, Kimberly Anderson, Lorinda B. McConnell, K. John |
author_sort | Rodriguez, Maria I. |
collection | PubMed |
description | BACKGROUND: In 2016, Oregon became the first of eight states to allow pharmacists to directly prescribe hormonal contraception (HC), including the pill, patch, or ring, without a clinic visit. In the two years following this policy change, the majority of ZIP codes across the state of Oregon had a pharmacist certified to prescribe HC. METHODS: We will utilize complementary methodologies to evaluate the effect of this policy change on convenient access to contraception (cost, supply dispensed), safety, contraceptive continuation and unintended pregnancy rates. We will conduct a prospective clinical cohort study to directly measure the impact of provider type on contraceptive continuation and to understand who is accessing hormonal contraception directly from pharmacists. We will concurrently conduct a retrospective analysis using medical claims data to evaluate the state-level effect of the policy. We will examine contraceptive continuation rates, incident pregnancy, and safety measures. The combination of these methodologies allows us to examine key woman-level factors, such as pregnancy intention and usual place of care, while also estimating the impact of the pharmacist prescription policy at the state level. DISCUSSION: Pharmacist prescription of HC is emerging nationally as a strategy to reduce unintended pregnancy. This study will provide data on the effect of this practice on convenient access to care, contraceptive safety and continuation rates. |
format | Online Article Text |
id | pubmed-6444429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64444292019-04-11 Pharmacists expand access to reproductive heaLthcare: PEARL study protocol Rodriguez, Maria I. Darney, Blair G. Edelman, Alison B. Yee, Kimberly Anderson, Lorinda B. McConnell, K. John BMC Health Serv Res Study Protocol BACKGROUND: In 2016, Oregon became the first of eight states to allow pharmacists to directly prescribe hormonal contraception (HC), including the pill, patch, or ring, without a clinic visit. In the two years following this policy change, the majority of ZIP codes across the state of Oregon had a pharmacist certified to prescribe HC. METHODS: We will utilize complementary methodologies to evaluate the effect of this policy change on convenient access to contraception (cost, supply dispensed), safety, contraceptive continuation and unintended pregnancy rates. We will conduct a prospective clinical cohort study to directly measure the impact of provider type on contraceptive continuation and to understand who is accessing hormonal contraception directly from pharmacists. We will concurrently conduct a retrospective analysis using medical claims data to evaluate the state-level effect of the policy. We will examine contraceptive continuation rates, incident pregnancy, and safety measures. The combination of these methodologies allows us to examine key woman-level factors, such as pregnancy intention and usual place of care, while also estimating the impact of the pharmacist prescription policy at the state level. DISCUSSION: Pharmacist prescription of HC is emerging nationally as a strategy to reduce unintended pregnancy. This study will provide data on the effect of this practice on convenient access to care, contraceptive safety and continuation rates. BioMed Central 2019-04-01 /pmc/articles/PMC6444429/ /pubmed/30935394 http://dx.doi.org/10.1186/s12913-019-4038-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Rodriguez, Maria I. Darney, Blair G. Edelman, Alison B. Yee, Kimberly Anderson, Lorinda B. McConnell, K. John Pharmacists expand access to reproductive heaLthcare: PEARL study protocol |
title | Pharmacists expand access to reproductive heaLthcare: PEARL study protocol |
title_full | Pharmacists expand access to reproductive heaLthcare: PEARL study protocol |
title_fullStr | Pharmacists expand access to reproductive heaLthcare: PEARL study protocol |
title_full_unstemmed | Pharmacists expand access to reproductive heaLthcare: PEARL study protocol |
title_short | Pharmacists expand access to reproductive heaLthcare: PEARL study protocol |
title_sort | pharmacists expand access to reproductive healthcare: pearl study protocol |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444429/ https://www.ncbi.nlm.nih.gov/pubmed/30935394 http://dx.doi.org/10.1186/s12913-019-4038-9 |
work_keys_str_mv | AT rodriguezmariai pharmacistsexpandaccesstoreproductivehealthcarepearlstudyprotocol AT darneyblairg pharmacistsexpandaccesstoreproductivehealthcarepearlstudyprotocol AT edelmanalisonb pharmacistsexpandaccesstoreproductivehealthcarepearlstudyprotocol AT yeekimberly pharmacistsexpandaccesstoreproductivehealthcarepearlstudyprotocol AT andersonlorindab pharmacistsexpandaccesstoreproductivehealthcarepearlstudyprotocol AT mcconnellkjohn pharmacistsexpandaccesstoreproductivehealthcarepearlstudyprotocol |